In a large Phase 3 clinical trial published in the New England Journal of Medicine, people who took the highest dose of the Wegovy pill lost an average of 16.6 percent of their body weight after 64 weeks
This shift in eating habits among GLP-1 users is an opportunity for the food industry, said Erin Russeck, Chief Research Officer at AMC Global
In this way, we were uniquely able to gather data from over 27,000 consented participants and to conduct a large-scale genetic study just one year after starting to collect data
I wanted to be able to run around with my kids and stay on my feet for longer periods without getting exhausted, said Kelsey
The insulin-like effect and inhibition of ACC benefit most patients with MASLD
Besides Wegovy, Novo Nordisk has two other semaglutide medications: once-weekly injectable Ozempic for type 2 diabetes and once-daily oral treatment Rybelsus for type 2 diabetes